Company Description
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally.
The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.
Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables.
The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications.
In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software.
Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
| Country | United States |
| Founded | 2006 |
| IPO Date | Jul 15, 2021 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 163 |
| CEO | Robert Spignesi |
Contact Details
Address: 25 Hartwell Avenue Lexington, Massachusetts 02421 United States | |
| Phone | 978 349 3200 |
| Website | rapidmicrobio.com |
Stock Details
| Ticker Symbol | RPID |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $20.00 |
| CIK Code | 0001380106 |
| CUSIP Number | 75340L104 |
| ISIN Number | US75340L1044 |
| Employer ID | 20-8121647 |
| SIC Code | 3826 |
Key Executives
| Name | Position |
|---|---|
| Robert G. Spignesi Jr. | Chief Executive Officer, President and Director |
| Sean M. Wirtjes CPA | Chief Financial Officer |
| John J. Addington Wilson | Chief Operating Officer |
| Michael Beaulieu C.F.A. | Vice President of Investor Relations and Corporate Communications |
| James Xu | Senior Vice President of Legal and Secretary |
| Julie Jarvie | Senior Vice President of Human Resources |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 8, 2025 | ARS | Filing |
| Apr 8, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 8, 2025 | DEF 14A | Other definitive proxy statements |
| Mar 4, 2025 | 8-K | Current Report |
| Feb 28, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 28, 2025 | 10-K | Annual Report |
| Feb 28, 2025 | 8-K | Current Report |
| Feb 27, 2025 | 8-K | Current Report |
| Jan 16, 2025 | 8-K | Current Report |
| Jan 14, 2025 | 8-K | Current Report |